ST吉药
(300108)
| 流通市值：10.90亿 | | | 总市值：11.06亿 |
| 流通股本：6.57亿 | | | 总股本：6.66亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 238,000,505.51 | 159,230,888.41 | 71,621,163.94 | 488,941,568.47 |
| 营业收入 | 238,000,505.51 | 159,230,888.41 | 71,621,163.94 | 488,941,568.47 |
| 二、营业总成本 | 408,993,813.69 | 268,161,659.56 | 127,061,747.57 | 792,350,877.77 |
| 营业成本 | 163,538,679.6 | 114,826,836.4 | 57,436,793.67 | 357,394,375.27 |
| 税金及附加 | 7,650,045.17 | 4,712,072.1 | 1,286,427.71 | 12,356,553.58 |
| 销售费用 | 40,843,916.6 | 22,074,552.72 | 10,311,426.99 | 66,091,622.51 |
| 管理费用 | 65,708,689.67 | 41,579,085.5 | 18,639,813.11 | 128,443,258.08 |
| 研发费用 | 6,129,842.08 | 4,242,001.1 | 2,099,855.68 | 17,997,376.97 |
| 财务费用 | 125,122,640.58 | 80,727,111.74 | 37,287,430.41 | 210,067,691.36 |
| 其中:利息费用 | 125,310,120.56 | 76,690,055.61 | 37,504,128.76 | 206,615,541.73 |
| 其中:利息收入 | 235,680.1 | 229,022.85 | 222,558.9 | 41,856.43 |
| 加:投资收益 | 19,964,005.22 | 19,943,899.21 | 29,982,396.34 | 158,895,761.46 |
| 资产处置收益 | 65,123.5 | 65,123.5 | -8,939.14 | -493,812.48 |
| 资产减值损失(新) | - | - | - | -21,441,425.95 |
| 信用减值损失(新) | -24,565,821.2 | -24,565,821.2 | - | -86,594,559.93 |
| 其他收益 | 179,882.49 | 71,154.76 | 38,440.44 | 12,744,766.57 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -175,350,118.17 | -113,416,414.88 | -25,428,685.99 | -240,298,579.63 |
| 加:营业外收入 | 84,097.25 | 66,915.84 | 12,730.09 | 344,341.91 |
| 减:营业外支出 | 22,269,198.78 | 14,126,817.15 | 4,411,185.96 | 39,230,237.97 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -197,535,219.7 | -127,476,316.19 | -29,827,141.86 | -279,184,475.69 |
| 减:所得税费用 | 3,801,350.59 | 2,315,654.58 | 1,137,545.92 | 7,683,198.26 |
| 六、净利润 | -201,336,570.29 | -129,791,970.77 | -30,964,687.78 | -286,867,673.95 |
| 持续经营净利润 | -201,336,570.29 | -129,791,970.77 | -30,964,687.78 | -286,867,673.95 |
| 归属于母公司股东的净利润 | -144,105,498.07 | -91,189,002.79 | -20,231,788.56 | -275,737,540.11 |
| 少数股东损益 | -57,231,072.22 | -38,602,967.98 | -10,732,899.22 | -11,130,133.84 |
| (一)基本每股收益 | -0.22 | -0.14 | -0.03 | -0.41 |
| (二)稀释每股收益 | -0.22 | -0.14 | -0.03 | -0.41 |
| 八、其他综合收益 | - | - | - | -9,769,367.42 |
| 归属于母公司股东的其他综合收益 | - | - | - | -9,769,367.42 |
| 九、综合收益总额 | -201,336,570.29 | -129,791,970.77 | -30,964,687.78 | -296,637,041.37 |
| 归属于母公司股东的综合收益总额 | -144,105,498.07 | -91,189,002.79 | -20,231,788.56 | -285,506,907.53 |
| 归属于少数股东的综合收益总额 | -57,231,072.22 | -38,602,967.98 | -10,732,899.22 | -11,130,133.84 |
| 公告日期 | 2023-10-26 | 2023-08-29 | 2023-04-28 | 2023-04-28 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |